|
10:00-12:00
|
Keynote presentations, Szentágothai Research Centre
Prof Metin Akay
University of Houston, Department of Biomedical Engineering, Houston, TX, USA
Biomedical engineering – from exoskeletons to human tissues
Prof. Metin Akay is currently the founding chair of the new Biomedical Engineering Department and the John S. Dunn professor of biomedical engineering at the University of Houston. He received hisB.S. and M.S. in Electrical Engineering from the Bogazici University, Istanbul, Turkey in 1981 and 1984, respectively and a Ph.D. degree from Rutgers University in 1990
Dr. Akay has played a key role in promoting biomedical education in the world by writing and editing several books, editing several special issues of prestigious journals, including the Proc of IEEE, and giving more than hundred keynote, plenary and invited talks at international conferences, symposiums and workshops regarding emerging technologies in biomedical engineering.
He is the founding editor-in-chief of the Biomedical Engineering Book Series published by the Wiley and IEEE Press and the Wiley Encyclopedia of Biomedical Engineering. He is also the editor of the Neural Engineering Handbook published by Wiley/IEEE Press and the first steering committee chair of the IEEE Trans on Computational Biology and Bioinformatics. He established the Annual International Summer School on Biocomplexity from Gene to System sponsored by the NSF and the IEEE EMBS and is the founding chair of the IEEE EMBS Special Topic Conference on Neural Engineering. He is also the chair of the IEEE EMBS Neuroengineering Technical Committee. He was the program chair of the International IEEE EMBS 2001 and the co-chair of the Annual International IEEE EMBS 2006 and the program co-chair of the Annual International IEEE EMBS 2011 conference which will be held in Boston. He currently serves on the advisory board of several international journals and on several NIH and NSF review panels.
Dr. Akay is a recipient of the IEEE EMBS Early Career and Service awards as well an IEEE Third Millenium Medal and is a fellow of IEEE, the Institute of Physics (IOP), the American Institute of Medical Biological Engineering (AIMBE) and the American Association for the Advancement of Science (AAAS). His Neural Engineering and Informatics Lab is interested in developing an intelligent wearable system for monitoring motor functions in Post-Stroke Hemiplegic Patients and detecting coronary artery disease. In addition, his lab is currently investigating the effect of nicotine on the dynamics of ventral tegmental area (VTA) dopamine neural networks as well as the detection of coronary occlusions.
Dr Jose Luis Carrillo Gamboa
Centro de Medicina Regenerativa, Querétaru, Mexico
3D bioprinting and how do we use it in Osteoarthritis lesions
Dr Jose Luis Carrillo Gamboa, orthopedic surgeon founded the cmrqro in 2015 and has been working intensely to apply adult stem cells in therapy. In his work Dr Gamboa placed absolute emphasis on ethical and professional conduct when using adult stem cells in therapy. Dr Gamboa has more than 10-year experience in this field, published numerous articles where he and his colleagues described their hands on experiences treating arthritis, knee and hip with the above methods.
Recently, Dr Gamboa made contact with Regemat, a company specializing in bioprinters and appointed them as scientific advisers in orthopedics. The work with Regemat begun in a framework of a clinical trial using a biodegradable 3D bio-printed scaffold enriched with adult stem cells. Such design facilitates cellular survival of stem cells within the scaffold. This method was recognized for its innovation and novel approach and was published in international publications. Using the above method, a cartilage that is awaiting for regeneration can be preordered with the adequate and sufficient number of cells and collagen II. Although still in a preliminary stage, production of such cartilage can reach the desired functional resistance to be implanted.
Dr Gamboa is a professor of the scientific and technological course of regenerative medicine recognized by the autonomous University of Querétaro. Dr José Luis Carrillo Gamboa received last 23 February the highest recognition of his medical career, he was awarded the Doctor Honoris Causa (DHC) title, granted by the Congress of the Union of the Mexican Government together with institutions of the university, communication and legal sectors.
Dr Gamboa is trained as an orthopedic traumatologist, surgery of hand pediatric traumatology, knee surgery and arthroscopy spine surgery and osteoporosis, Mexican Council of Orthopedics and Traumatology, ethics and research committees hospital h + queretaro, AAOS American Academy Orthopaedics Surgeon, American Academy of Spine Surgeons NASS, active member of the International Cartilage Repair Society ICRS since 2016. Latin American Federation of Societies and Associations of Orthopedics and Traumatology SLAOT certified as international lecturer at the xxiii International Congress slaot. August 2015 Latin American Federation of Societies and Associations of Orthopedics and Traumatology SLAOT diploma is granted as an international member. Eurospine 2015 certificate as a member of continuing medical education September 2015. Copenhagen, Denmark. Active member igf International Geriatric Fracture Society 2015. Speaker training of Forteo Lilly Laboratories. Fix & treat to orthopedists and traumatologists. Differentiation between antiresorptive and anabolic treatments, 2017 Veracruz, México. Presentation at the First Conference on Chronic Degenerative Diseases in Belgium September 2016, very satisfactory results on treatment with BMAC in carpal trapezius articulation. Presentation of more cases at the Ibero-Latin American Congress of Cancun Mex in April 2018.
Dr Glauco R. Souza
Director of Global Business Development and Innovation, 3D Cell Culture
Greiner Bio-One
Adjunct Assistant Professor, University of Texas Health Science Center at Houston, TX USA
Magnetic 3D Bioprinting, from Generating Spheroids to Fingerprinting Cell-Types
Dr. Glauco R. Souza is the President, CSO, and co-founder of Nano3D Biosciences, Inc. (n3D). He is one of the co-inventors and inventor of all eleven patents related to magnetic 3D cell, including magnetic 3D bioprinting and levitation technologies. Dr. Souza is also Adjunct Assistant Professor at University of Texas Health Science Center at Houston. Prior to co-founding n3D, Dr. Souza was an Odyssey Scholar at UT MD Anderson Cancer Center. During his work at MD Anderson, he applied a multidisciplinary approach to developing nanotechnology tools for tissue targeted imaging, gene delivery, and tissue engineering. Towards the end of his Odyssey Scholarship tenure at MD Anderson, in collaboration with Rice University, the genesis of 3D cell culturing by magnetic levitation and magnetic 3D bioprinting took place. Results using these groundbreaking technologies have been reported in various high-impact scientific journals, including Nature Nanotechnology, Proceedings of the National Academy of Sciences, Nature Protocols, Biomaterials, and Nature Reviews Cancer. Now, Glauco’s mission is to advance magnetic 3D cell culture into a routine laboratory tool that will measurably improve the drug discovery process, cancer research, personalized medicine, and regenerative medicine. Recently, his work was selected for the Short List of The 2017 Lush Prize for outstanding research producing an effective non-animal safety test. He was also an invited speaker at TEDx Houston. Dr. Souza’s research has been funded by grants from National Science Foundation (NSF), National Institute of Health (NIH), Department of Defense (DOD), Center for Advancement of Science in Space (CASIS), and Texas Emerging Technology Fund (ETF). Glauco received B.S. in Chemistry and M.S. and Ph.D. in Physical Chemistry from The George Washington University in Washington DC (GWU).
Contact information
gsouza@n3dbio.comor
www.linkedin.com/profile/public-profile-settings?trk=prof-edit-edit-public_profile
www.researchgate.net/profile/Glauco_Souza
Dr Krisztián Fodor
National Institute of Phamramcy and Nutrition
Bioprinted medicinal products and the ATMP regulation
Contact: fodor.krisztian@ogyei.gov.hu
More information: innovacio.ogyei.gov.hu
Krisztián had been engaged in basic scientific research for 14 years focusing on structure-function relationship of protein macromolecules. He awarded doctorate (PhD) at the Faculty of Biochemistry of Lorand Eotvos University (Hungary). He had been involved in several European research projects as a postdoctoral fellow at the European Molecular Biology Laboratory (Hamburg, Germany). His expertise includes bioanalytics and regulatory assessment of biological medicinal products. He is a former member of the EMA Committee for Advanced Therapies (CAT) where he acted as a Hungarian representative for three years. He is involved in the assessment of the quality dossiers of marketing authorization applications and clinical trial applications of various biologics including advanced therapies. As the directing manager of the Strategy, Methdology and Development Department of OGYÉI, he is responsible for the efficient operation of the Innovation Office.
|
